Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Insilico Biotechnology
Insilico Biotechnology
Activities:
Ingredients
Pharmaceutical
X
LinkedIn
Trending Articles
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
ChargePoint invest in a single-use manufacturing facility to expand product line
The single-use manufacturing facility will become fully operational in June 2024, and will support the company's trio of liquid and powder transfer devices
COVID-19 still a significant risk for the immunocompromised, study finds
AstraZeneca's INFORM study highlights the persistent danger of COVID-19 for the immunocompromised despite the vaccination scheme
Broughton receives flexible scope ISO 17025 accreditation
New certification allows accreditation without prior approval
Upcoming event
ASGCT Annual Meeting 2024
7-11 May, 2024 | Meeting | Portland, OR
See all
Related Content
Manufacturing
Yokogawa acquires bioprocessing digital twin expert
The company has acquired Insilico Biotechnology to build its biopharma offering
Finance
Insilico and 2-control work towards the smart biofactory
The agreement follows Insilico's previous collaboration with Meyer Chroma Technology
Manufacturing
Insilico Biotechnology moves into the US predictive twin market
Insilico Biotechnology has announced the opening of its first subsidiary in the US, located in Boston, Massachusetts
Manufacturing
Insilico and Janssen take another step towards predictive biomanufacturing
The digital twins collaboration will run for three years and will be based at Insilico's site in Stuttgart, Germany and at Janssen's Spring House location in the US
Manufacturing
Insilico works with university on digital twins for antibody production
The German collaboration aims to enable true online-control of critical quality attributes such as the glycosylation profile
Subscribe now